A biotechnology company focused on developing antiviral and specialty medicines, with leading franchises in HIV treatment and prevention as well as therapies for hepatitis and certain cancers. Its portfolio includes widely used antiretroviral drugs and cell therapies acquired through strategic acqui...
No congressional trades have been disclosed for gilead Sciences Inc. (GISC) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
No congressional trades found for this stock.